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The mutational changes needed to create a cancer cell have been
itemised in great detail (Hahn and Weinberg, 2002). These
mutations are commonly assumed to accumulate over the course
of years as a consequence of spontaneous replication errors or, in
special cases, the misrepair of DNA lesions introduced by
carcinogens such as tobacco smoke or sunlight. Yet, there are
numerous discrepancies between the mutagenicity of chemicals
and their danger to humans (Clemmesen and Hjalgrim, 1977;
Jansen et al, 1980; Ames et al, 1987), and the time course of
carcinogenesis is deeply mysterious. Indeed, we still do not know
the proximate causes of most cancers even though these are what
we want to learn how to avoid.
The classical method for creating cancers, in rabbits (Friedewald
and Rous, 1944) in mice (Berenblum and Shubik, 1947) and
perhaps in humans (Pott, 1775), by applying coal tar to the skin,
involves a sequence of steps, called initiation and promotion
(Friedewald and Rous, 1944), which bear no obvious relation to
what is now known about the molecular biology of cancer. For
example, a mouse can be ‘initiated’ by feeding it once with 1mg
of the coal tar derivative 9,10-dimethyl-1,2-benzanthracene
(Boutwell, 1964). This single treatment with a mutagen apparently
causes cells to undergo a permanent change so that, for the rest of
the mouse’s life, its skin has become susceptible to the production
of papillomas and carcinomas on exposure to the non-mutagenic
irritants in croton oil. Surprisingly, a similar sequence has been
seen using cells in vitro, where brief exposure to X-rays or
methylcholanthrene apparently produces a permanent change in
every cell so that, many generations later, its descendants
occasionally undergo ‘spontaneous’ transformation into cancer
cells (Kennedy et al, 1980, 1984). Why does there have to be a long
interval between a cell’s exposure to a mutagen and the expression
of the resulting mutations, and why do only a minority of the cell’s
descendants express these mutations?
It would have been tempting to postulate that the various
methods for producing cancer in the cells of animals are not good
models of human carcinogenesis, were it not for the fact that
humans and animals show the same strange relationship between
dose of carcinogen and time of appearance of their cancers. For
example, although the incidence of lung cancer in smokers appears
to be directly proportional to the number of cigarettes smoked per
day (Zaridze and Peto, 1986), it is proportional to roughly the sixth
power of the duration of smoking. Similarly, when rats are
continuously exposed to dietary carcinogens, their incidence of
cancer rises as the first or second power of the dose rate but as a
much higher power of time (Druckrey, 1967; Peto et al,1 9 9 7 ) .I ft h e
carcinogen had simply to mutate a set of N genes to create cancer,
the frequency of cancer should rise as the Nth power
of the dose, and time would not be a major factor. These
numerous experiments suggest, therefore, that mutagenic carcino-
gens cause just one or two events and that these (similar to the
initial event in in vitro carcinogenesis) are then followed by
steps that accumulate solely with the passage of time, driven
perhaps by cell division. Thus, the rabbit whose ears have been
painted with coal tar tends to develop its skin cancers where,
months later, samples of its skin were excised and therefore had to
be replaced by extra division in the surrounding epithelium (Linell,
1947). To take two well-documented examples of carcinogenesis in
humans, a chimney sweep did not get scrotal cancer until
after puberty when he had grown too large to climb chimneys
(Pott, 1775); and smokers keep their raised rate of lung cancer for
many years after they have stopped smoking (Halpern et al, 1993).
To recapitulate, there are examples where the sequence changes
found in cancer cells are the type known to be produced by the
initiating carcinogen (Brash et al, 1991; Hsu et al, 1991; Hainaut
and Pfeifer, 2001), but the study of cancer in humans and animals,
overall, has produced a very confused picture. The techniques of
modern molecular biology have documented the many defects of
cancer cells, so there is by now a fairly clear understanding of the
basis for the dangerous properties of cancer cells. However, the
picture that emerges from the classical studies of the epidemiology
of human cancers and of experimental carcinogenesis in animals is
hard to reconcile with what has been learnt about mutagenesis in
simple systems such as the bacteria. Initiation seems to be far too
efficient to be simply mutagenesis of certain oncogenes and
suppressor genes, and the subsequent time-dependent steps are
even more obscure.
In recent years, it has become plain that the management of
biological information involves several unexpected mechanisms
that limit the consequences when nucleic acids and proteins are
damaged. Interactions between cells can protect against their
individual defects (Rubin, 2006) and, on a larger scale, the
expansion of abnormal clones can be inhibited by their normal
neighbours (Chao et al, 2008). Within each individual cell, there is
a large set of ‘heat-shock proteins’ (HSPs) that manages the folding
and operation of the products of gene expression, and one of the
actions of these HSPs is to sequester or remove the abnormal
proteins produced as the result of mutation or chance misfolding.
After exposure to harsh environmental conditions such as a
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HSPs is altered, and the inactivation of one of the many HSP genes
has been shown to result in the expression of previously hidden
mutations, suggesting that one function of HSPs is to allow
complex evolutionary steps to occur under conditions of stress
even when the changes entail a combination of several individually
disadvantageous steps (Rutherford and Lindquist, 1998). Keeping
those mutations masked may contribute to tumorigenesis, because
inactivation of one of the HSP genes has been found to lower the
frequency of skin cancer in mice exposed to initiation by
dimethylbenzanthracene and promotion by phorbol esters (Dai
et al, 2007).
The prime mystery in carcinogenesis remains the very first step,
because it is hard to imagine how the numerous genetic changes
found in cancer cells could have been produced in any cell as the
result of a single exposure to a DNA-damaging agent, or why
months or years should have to elapse before the effect of these
changes is observed. Past speculations about the process of
carcinogenesis (as opposed to the characteristics of the end
product) have had little popularity and negligible impact. Indeed,
the early suggestions that cancer cells owe their properties to
mutation (Tyzzer, 1916) and that carcinogens interact with DNA
(Boyland, 1952) were, in their time, violently attacked (Miller and
Miller, 1952; Rous, 1959). Now, perhaps with all these recent
discoveries of additional mechanisms that protect cells from
damage, it may soon be possible to produce a plausible model for
what is going on during carcinogenesis. At least one new idea
seems to be needed, and the main purpose of this article is to alert
readers to new developments that could at last start to clarify what
is going on during carcinogenesis.
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